Dr. Christopher Erik Lominska, MD

Dr. Lominska practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Lominska's NPI, 1366683864, was assigned on March 12, 2009. Dr. Lominska graduated from Vagelos College of Physicians and Surgeons in 2005. Dr. Lominska's Kansas license number on file is 04-34596.

Dr. Lominska's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Lominska's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Lominska is also affiliated with The University of Kansas Health System Olathe Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Lominska to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lominska practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Lominska's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Lominska is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Lominska's licenses on file in 6 states: Kansas, Colorado, Missouri, Nebraska, New Mexico and District of Columbia.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, cancer radiation-upper GI and head & neck cancer radiation among the conditions Dr. Lominska treats.

CMS data shows 1,929 Medicare services from Dr. Lominska across 18 procedure codes in 2024, for 406 Medicare patients. Medicare paid $112,475 for them.

CMS counts 406 Medicare patients who saw Dr. Lominska in 2024. The largest group is 65 to 74, with 230 patients. 73% of them have high blood pressure, and 73% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lominska's median patient age at 71, with 35% women.

In 2024, Dr. Lominska wrote 444 Medicare Part D claims for 126 patients. 83% of them were for generic drugs. CMS names the drug for 302 of them, across 11 drugs with 11 or more claims each, at $7,560 in total drug cost. In 2023, CMS named 416 claims across 13 drugs.

Dr. Lominska accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lominska as offering telehealth.

Dmand AI links 31 papers to Dr. Lominska, published from 2010 to 2024. 2016 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Radiotherapy, Intensity-Modulated and Radiosurgery. Dr. Lominska has published most often in J Appl Clin Med Phys. Dr. Lominska's most frequent co-authors are Gregory N. Gan, MD, PhD, Kiran Kakarala, MD and Ryan Taylor Morse, MD.

Dmand AI links Dr. Lominska to 8 clinical trials, 4 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Rectal Neoplasms, Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 2 general payments to Dr. Lominska from 1 drug or device company in 2019. Travel and lodging make up the largest share, 100% of the total. Mevion_Medical_Systems_Inc paid the most, $466.

Dr. Lominska graduated from Vagelos College of Physicians and Surgeons in 2005.

Dr. Lominska is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.